BOSTON and ROCHESTER, N.Y., April 9, 2014 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has received the "Product of the Year 2013" Award from the German journal Aesthetic Dermatology for its VivaScope® system.
In an award feature titled "Confocal laser scanning microscopy: Renowned office diagnostics with integrated dermoscopy offers highest certainty," the journal notes: "The VivaScope 1500 unit and the mobile VivaScope 3000 handheld unit ... offer modern, in-vivo diagnostics for sophisticated offices." After describing the operation of VivaScope, the feature continues: "This enables comprehensive diagnostics of the highest degree. With regard to the early detection of skin cancer, the number of excisions is thus decreased with comparable certainty." The feature includes testimonials about VivaScope from six medical professionals in Germany.
L. Michael Hone, Chief Executive Officer of Caliber I.D., said, "We are pleased that Aesthetic Dermatology has chosen to distinguish us with this honor. It is great to acknowledge that medical professionals in Germany have found VivaScope to be useful in their practice and appealing to their patients. It is also a testament to the performance of our European distributor, MAVIG GmbH, who have made our devices available for sale in Germany."
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' proprietary, cutting-edge VivaScope(R) system is a disruptive, noninvasive point-of-care platform imaging technology with numerous applications in dermatology, surgery and research. FDA 510(k) cleared, VivaScope has regulatory approval in most major markets. With 78 issued and pending patents worldwide, VivaScope significantly improves outcomes and reduces costs, allowing physicians to quickly detect cancerous lesions that appear benign. VivaScope dramatically reduces the need for expensive, painful and time-consuming biopsies, which show no malignancy approximately 70% of the time. VivaScope also has significant applications in testing and analysis in the cosmetics industry. For more information about Caliber I.D. and its products, please visit www.caliberid.com.
VivaScope(R) is a registered trademark of Caliber Imaging & Diagnostics.
This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995, including the statements regarding the potential for future product revenue growth and financial performance. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the 2013 10-K filed by us with the Securities and Exchange Commission.
CONTACT: Company Contact: Richard Christopher Chief Financial Officer (617) 348-9821 firstname.lastname@example.org Investor Relations Contact: LHA Kim Sutton Golodetz (212) 838-3777 email@example.com Public Relations Contacts: Dian Griesel Int'l. Susan Forman or Laura Radocaj (212) 825-3210 firstname.lastname@example.org email@example.comSource:Caliber Imaging & Diagnostics, Inc.